Axomove, a digital health company backed by Faraday Venture Partners, has closed a €4 million Series A financing round to accelerate the deployment of its digital medical device for prevention and rehabilitation.

The round was co-led by Bpifrance’s Digital Prevention Fund and GO CAPITAL, with the participation of INCO Ventures and existing investor Faraday Venture Partners, reinforcing its continued support for the company in this new growth phase.

Beyond the funding itself, investors highlight the strong fundamentals behind the business: a reimbursed digital medical solution already integrated into the healthcare system, proven product-market fit, and measurable clinical outcomes in a large and still under-digitised market.

Axomove is currently the only solution in its category reimbursed by the French National Health Insurance for chronic lower back pain, strengthening its position within the European healthcare ecosystem.

The new funding will support three key strategic priorities:

  • Commercial expansion across insurers, employers and healthcare providers
  • Extension of reimbursement coverage to additional medical conditions
  • Continued improvement of the product and user experience

The company’s mission remains to prevent and treat musculoskeletal disorders through movement-based therapy, with the goal of improving long-term clinical outcomes and patient care pathways.

Both investors and the founding team view this round as a key milestone in scaling the company’s impact and reinforcing its role within modern healthcare systems

Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

The Worst Business in the World That Eve...

by Bondo Advisors

Football clubs trade at absurd multiples, private equity funds keep pa...

Photos Stream